Login / Signup
Improvements in quality of life and work productivity make omalizumab cost-effective for the treatment of chronic spontaneous urticaria.
Margarida Gonçalo
Published in:
The British journal of dermatology (2019)
Keyphrases
</>
climate change
smoking cessation